2024    2023    2022    2021    2020    2019    2018    2017    2016   

2018

Articles

71 - 

Value of Myocardial Work Estimation in the Prediction of Response to Cardiac Resynchronization Therapy

Elena Galli, Christophe Leclercq, Maxime Fournet, Arnaud Hubert, Anne Bernard et al.

Journal of The American Society of Echocardiography, 2018, 31 (2), pp.220-230.

DOI : https://doi.org/10.1016/j.echo.2017.10.009

Pubmed : 29246513

 

72 - 

Outcome After Reperfusion Therapies in Patients With Large Baseline Diffusion-Weighted Imaging Stroke Lesions A THRACE Trial (Mechanical Thrombectomy After Intravenous Alteplase Versus Alteplase Alone After Stroke) Subgroup Analysis

V. Gautheron, Y. Xie, M. Tisserand, Hélène Raoult, S. Soize et al.

Outcome After Reperfusion Therapies in Patients With Large Baseline Diffusion-Weighted Imaging Stroke Lesions A THRACE Trial (Mechanical Thrombectomy After Intravenous Alteplase Versus Alteplase Alone After Stroke) Subgroup Analysis. Stroke, 2018, 49 (3), pp.750-753.

DOI : https://doi.org/10.1161/STROKEAHA.117.020244

Pubmed : 29382803

 

73 - 

Cerebral aspergillosis: An emerging opportunistic infection in patients receiving ibrutinib for chronic lymphocytic leukemia? Aspergillose cérébrale : une infection opportuniste émergente chez les patients traités par ibrutinib pour leucémie lymphoïde chronique ?

E Gaye, Audrey Le Bot, Jean-Philippe Talarmin, Ronan Le Calloch, Sorya Belaz et al.

Cerebral aspergillosis: An emerging opportunistic infection in patients receiving ibrutinib for chronic lymphocytic leukemia?. Médecine et Maladies Infectieuses, 2018, 48 (4), pp.294-297.

DOI : https://doi.org/10.1016/j.medmal.2018.01.003

Pubmed : 29402474

 

74 - 

Dyserythropoiesis in the diagnosis of the myelodysplastic syndromes and other myeloid neoplasms problem areas

J.E. Goasguen, J.M. Bennett, B.J. Bain, R. Brunning, M.-T. Vallespi et al.

British Journal of Haematology, 2018, 182 (4), pp.526-533.

DOI : https://doi.org/10.1111/bjh.15435

Pubmed : 29917221

 

75 - 

How can we best monitor 5-FU administration to maximize benefit to risk ratio?

Françoise Goirand, Florian Lemaitre, Manon Launay, Camille Tron, Etienne Chatelut et al.

Expert Opinion on Drug Metabolism and Toxicology, 2018, 14 (12), pp.1303-1313.

DOI : https://doi.org/10.1080/17425255.2018.1550484

Pubmed : 30451549

 

76 - 

Updated French practical guidelines on the management of dabigatran-treated patients

Isabelle Gouin-Thibault, Jean-Christophe Gris

Anaesthesia Critical Care & Pain Medicine, 2018, 37 (4), pp.311--312.

DOI : https://doi.org/10.1016/j.accpm.2018.07.004

Pubmed : 30055827

 

77 - 

A systematic literature review on solitary rectal ulcer syndrome is there a therapeutic consensus in 2018?

Claire Gouriou, Marion Chambaz, Alain Ropert, Guillaume Bouguen, Véronique Desfourneaux et al.

International Journal of Colorectal Disease, 2018, 33 (12), pp.1647-1655.

DOI : https://doi.org/10.1007/s00384-018-3162-z

Pubmed : 30206681

 

78 - 

Impaired efferocytosis and neutrophil extracellular traps clearance by macrophages in ARDS

Murielle Gregoire, Fabrice Uhel, Mathieu Lesouhaitier, Arnaud Gacouin, Marion Guirriec et al.

European Respiratory Journal, 2018, 52 (2), pp.1702590.

DOI : https://doi.org/10.1183/13993003.02590-2017

Pubmed : 29946009

 

79 - 

Comorbidités mentales et sclérose en plaques : étude française à partir des données de l’Assurance maladie

A. Guilleux, Jonathan Roux, Emmanuelle Leray

Epidemiology and Public Health = Revue d'Epidémiologie et de Santé Publique, 2018, 66 (suppl 1), pp.S44.

DOI : https://doi.org/10.1016/j.respe.2018.01.098

 

80 - 

Care-seeking and disease modifying therapies use among multiple sclerosis patients with and without mental disorders - a population-based study

A. Guilleux, Jonathan Roux, Emmanuelle Leray

Multiple Sclerosis Journal, 2018, 24, pp.377-378.